Ubs Oconnor LLC Galapagos Nv Transaction History

Ubs Oconnor LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$34.17 - $42.98 $1.57 Million - $1.98 Million	-46,000 Reduced 80.86%	10,888 $376,000
Q2 2023 Aug 14, 2023	BUY	$37.4 - $44.52 $2.13 Million - $2.53 Million	56,888 New	56,888 $2.31 Billion
Q1 2023 May 15, 2023	BUY	$36.5 - $48.0 $1.51 Million - $1.98 Million	41,250 New	41,250 $1.59 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.87B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

Stay updated on Ubs Oconnor LLC with notifications on news.